SCHEMBL28052513

SCHEMBL28052513

Fc1cc(-c2cc[nH]n2)ccc1OC(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.46
PDE4A P27815 2/20 0.46
PDE4B Q07343 2/20 0.46
PDE4C Q08493 2/20 0.46
PDE4D Q08499 2/20 0.46
PDE3B Q13370 2/20 0.46
PDE3A Q14432 2/20 0.46
LMNA P02545 2/20 0.46
TP53 P04637 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
CYP2C19 P33261 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
GRIN2B Q13224 7/20 0.39
GRM2 Q14416 4/20 0.36
NPC1 O15118 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3605697 0.87 PDE4D (0.55) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL12096338 0.81 SMN1; SMN2 (0.54) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL3103824 0.78 NOTUM (0.43) CYP1A2CYP2C9MAPK1CYP2C19NPC1
SCHEMBL30745584 0.78 NOTUM (0.43) CYP1A2CYP2C9MAPK1CYP2C19NPC1
SCHEMBL14911053 0.78 PDE4A (0.46) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL31662983 0.77 PDE4A (0.45) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL17003768 0.76 PDE4D (0.50) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL30244557 0.76 GRIN2B (0.40) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL6774958 0.76 SCN4A (0.43) ALDH1A1MAPT
SCHEMBL27394120 0.73 ALDH1A1 (0.41) SMN1; SMN2PDE3BPDE3ALMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105431437-A PI3K protein kinase inhibitors, in particular inhibitors and/or gamma inhibitors RHIZEN PHARMACEUTICALS SA 2016-03-23 CN disclosed